Clinical Trial: Measurement of Urinary Hormones in Patients With Abnormal Uterine Bleeding to Study Uterine Cancer Progression

U.S., May 13 -- ClinicalTrials.gov registry received information related to the study (NCT07581288) titled 'Measurement of Urinary Hormones in Patients With Abnormal Uterine Bleeding to Study Uterine Cancer Progression' on April 08.

Brief Summary: The investigators will obtain urine hormone results and validated menstrual bleeding score from people experiencing abnormal uterine bleeding. The investigators will evaluate satisfaction and ease of use of Mira monitor. The investigators will measure recruitment rate, attrition and cycle collection completeness of data. The investigators will evaluate menstrual health literacy at baseline and at the conclusion of the study.

Study Start Date: May, 2026

Study Type: OBSERVATIONAL

Condition: Ute...